The study is in JAMA, July 3, 2019: Association between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men with Prostate Cancer. R. Jayadevappa, S. Chhatre, B. Malkowicz et al. Google ADT alzheimer and it's the fourth hit. I tried creating a link to the URL and it wouldn't work for some reason.
The article breaks down risk by dose of ADT: 1-4 doses, 5-8 doses, and >8 doses, but I don't see a definition of "dose" -- if anyone can find it, please help me out. Also, not clear what regimen of ADT qualified. The usual caveats about
I happened to see an MO for the first time yesterday, and he mentioned this study to me. He seemed glad I stopped ADT after one year. ... MO doesn't mean bad news on my end, btw. The Saipan hospital just hired an MO, for the first time in my 12 years here, and my PCP referred me to him for routine followups. Seemed a good idea, and he made a favorable impression on me. All's well (pending results of yesterday's blood draw, of course).
Age 60 at dx 7/2017 biopsy G8 (4+4), 5/13 cores
RARP 8/2017 (Patel), pT3a N0 M0, 30% tumor; EPE+, SV-
PSA 1/2016, 2.9; 4/2017, 7.2; 9/2017 (post-RARP), 0.13; 10/2017, <0.05, 1/9/2018, 0.09, 2/23/2018, 0.08.
SRT 72Gy, 40 fractions, finished 5/8/2018, plus 12 months ADT, finished 2/2019, PSA <0.02, T=4
Caution: I’m not an MD and don’t know what I’m talking about
Post Edited (Saipan Paradise) : 8/19/2019 9:26:13 PM (GMT-6)